Expertise in
9
conditions

Dr. Richard Lauer

Hematology
Office
Albuquerque, NM 
Expertise in
9
conditions
Office
Albuquerque, NM 

Overview

Richard Lauer is a Hematologist in Albuquerque, New Mexico. Dr. Lauer is highly rated in 9 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Multiple Myeloma, and Prostate Cancer.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in NM

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
Albuquerque, NM 87102
Other Locations
University of New Mexico Medical Group Inc
933 Bradbury Dr SE Ste 2222, Albuquerque, NM 87106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
Enrollment Status: Completed
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drugs: TAK-700, Bicalutamide
Study Phase: Phase 3
Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-Ineligible) in Subjects With T2-4aN0M0 Urothelial Cancer: HCRN GU14-188
Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-Ineligible) in Subjects With T2-4aN0M0 Urothelial Cancer: HCRN GU14-188
Enrollment Status: Completed
Publish Date: March 18, 2025
Intervention Type: Drug, Procedure
Study Drugs: Pembrolizumab, Gemcitabine, Cisplatin
Study Phase: Phase 1/Phase 2
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Procedure, Drug
Study Drugs: Cabozantinib S-Malate, Crizotinib, Savolitinib, Sunitinib Malate
Study Phase: Phase 2
A Randomized, Double-blinded, Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer: Hoosier Cancer Research Network GU14-182
A Randomized, Double-blinded, Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer: Hoosier Cancer Research Network GU14-182
Enrollment Status: Completed
Publish Date: September 30, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2 Open-label Study to Evaluate the Efficacy and Safety of Seviteronel in Subjects With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone
A Phase 2 Open-label Study to Evaluate the Efficacy and Safety of Seviteronel in Subjects With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

11 Total Publications

Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Journal: eLife
Published: July 16, 2022
Similar Doctors
Leslie Andritsos
Expertise in
24
conditions
Dr. Leslie Andritsos
Hematology
Expertise in
24
conditions
Dr. Leslie Andritsos
Hematology

Cancer Center Pharmacy

Albuquerque, NM 
 (2.2 miles away)
505-272-4946
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leslie Andritsos is a Hematologist in Albuquerque, New Mexico. Dr. Andritsos is highly rated in 24 conditions, according to our data. Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Splenectomy.

Expertise in
31
conditions
Dr. Ian Rabinowitz
Hematology
Expertise in
31
conditions
Dr. Ian Rabinowitz
Hematology

UNM Medical Group Inc

Albuquerque, NM 
 (2.2 miles away)
505-272-4946
Languages Spoken:
English
See accepted insurances

Ian Rabinowitz is a Hematologist in Albuquerque, New Mexico. Dr. Rabinowitz is highly rated in 31 conditions, according to our data. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Ependymoma, Atypical Teratoid Rhabdoid Tumor (ATRT), and Neuroepithelioma.

Expertise in
15
conditions
Dr. Matthew Fero
Hematology | Oncology
Expertise in
15
conditions
Dr. Matthew Fero
Hematology | Oncology

Cancer Center Pharmacy

Albuquerque, NM 
 (2.2 miles away)
206-288-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Matthew Fero is a Hematologist and an Oncologist in Albuquerque, New Mexico. Dr. Fero is highly rated in 15 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Multiple Myeloma, Classical Hodgkin Lymphoma, and Richter Syndrome.

Frequently Asked Questions about Dr. Richard Lauer

How do I make an appointment with Dr. Richard Lauer?

You can book an appointment with Dr. Richard Lauer by calling their office at 505-272-4946. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard Lauer a top-rated expert for Familial Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard Lauer is classified as an Distinguished expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard Lauer specialize in?

While Dr. Richard Lauer is a Hematology, they have specific expertise in Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Richard Lauer participate in research or clinical trials?

Yes. Dr. Richard Lauer has published 11 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Dr. Richard Lauer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lauer's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 105 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile